PCP
ZSAN

Proficio Capital Partners’s Zosano Pharma Corporation ZSAN Stock Holding History

Proficio Capital Partners’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-571
Closed -$82K – 1324
2018
Q2 		$82K Buy
+571
New +$86K 0.03% 238

Other funds holding ZSAN

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Proficio Capital Partners's ZSAN Position: Q3 2018 in Review

Proficio Capital Partners sold out of Zosano Pharma Corporation (ZSAN) in Q3 2018, closing a stake of 571 shares — an estimated $82K sold.

Proficio Capital Partners first reported a position in ZSAN in Q2 2018 and held it in 1 quarter. The position peaked at $82K in Q2 2018. 23 funds tracked by Wall St. Rank hold ZSAN as of Q3 2018.

  • Proficio Capital Partners reported no remaining Zosano Pharma Corporation position as of Q3 2018 after selling out during the quarter.
  • Proficio Capital Partners sold 571 Zosano Pharma Corporation shares in Q3 2018, an estimated $82K.
  • Proficio Capital Partners first reported a position in Zosano Pharma Corporation in Q2 2018 and held it in 1 quarter.
  • Proficio Capital Partners's Zosano Pharma Corporation position peaked at $82K in Q2 2018.
  • 23 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q3 2018.

Based on Proficio Capital Partners's 13F filing for Q3 2018, filed 13 Nov 2018.